[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07615816":3,"trial-entities:NCT07615816":139,"trial-summary:NCT07615816":142},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":21,"study_type":23,"primary_purpose":24,"phases":25,"enrollment_info":27,"interventions":30,"primary_outcomes":41,"secondary_outcomes":72,"sex":73,"minimum_age":74,"maximum_age":75,"healthy_volunteers":14,"eligibility_criteria":76,"std_ages":107,"locations":109,"central_contacts":128,"overall_officials":133,"references":137,"see_also_links":138},"NCT07615816","226029","Investigating Medical Massage Therapy for Patients With Sub-Acute Lower Back Pain","RECRUITING","2027-01-31","2026-06","2026-06-05","2026-06-01","The Geneva Foundation","OTHER",false,"The goal of this clinical trial is to determine if a weekly regimen of Medical Massage Therapy (MMT) with provider-directed care shortens the duration of Medically Restricted Duty Days (MRDD) periods in Active-Duty Service Members with Subacute Lower Back Pain (LBP) compared to provider-directed care alone.\n\nThe main question the study aims to answer is, when used as an adjunct to provider-directed care, a consistent program of MMT provided by a qualified practitioner, will shorten the duration of MRDD periods, reduce pain, and decrease unnecessary healthcare utilization in patients with Subacute LBP compared to provider-directed care alone. Researchers will study this hypothesis through the comparison of Group #1 (provider-directed care alone) and Group #2 (provider-directed care and MMT).\n\nParticipants randomized into the two study groups will be following a 12-week study design (+\u002F- 2 weeks) comprised of their compliance to their provider-directed care, the study intervention (if randomized to Group #2) and study case report forms (CRFs); with a final follow up visit (up to 4 weeks following their final treatment visit).","Musculoskeletal injuries (MSKI) affect approximately 800,000 service members (SMs) annually and result in 25 million days of limited duty. These conditions account for 34% of medical evacuations from theatre, and are the primary reasons for medical separation. Low back pain (LBP) is the leading cause of MSKI amongst active-duty service members (ADSMs) with a lifetime prevalence rate of up to 80%. The burden of disease for LBP is reaching $100 billion annually in the United States and new methods for prevention and treatment are necessary.\n\nAt the present time, there is no \"gold standard\" for LBP management and strong evidence as to what is most beneficial is lacking. One of the most promising medical options for LBP is massage therapy (MT), given that no special equipment is needed, it can be delivered anywhere, it is non-habit forming, and the likelihood for serious harm is low. Massage therapy is unique in that it can naturally enhance local blood flow, thereby providing vital oxygen and nutrients to areas damaged by MSKI to promote healing, offers relaxation and normalization of soft tissue which reduces pain, lessens swelling, clears local pain mediators, improves cognitive\u002Fpsychosocial complications (e.g., depression, anxiety, etc.), aids in sleep quality, and provides a positive hormone release. To date, however, there has not been a large randomized control trial (RCT) performed on patients with subacute LBP to demonstrate healing and preventing patients from becoming chronically injured.\n\nTo address this limitation, we will enroll a total of 200 patients to assess the efficacy of medical massage therapy (MMT) combined with standard of care (SoC) in ADSMs with subacute LBP (intervention) as compared to SoC only (control). Five specific aims have been designed to understand if weekly MMT can reduce medically restricted duty days (MRDD) (Aim #1), decrease pain\u002Fdisability and improve sleep quality (Aim #2), and lessen the need for prescription medications (Aim #3). Data will be aggregated at the end of the study through survey tools and self-reported information to understand the economic impact of (Aim #4) and to understand which patient phenotypes are optimal for future care (Aim #5).",[18,19,20],"Lower Back Pain","Subacute Lower Back Pain","Medical Massage Therapy",[20,22,19,18],"Active Duty Service Members","INTERVENTIONAL","TREATMENT",[26],"NA",{"count":28,"type":29},220,"ESTIMATED",[31,36],{"type":32,"name":20,"description":33,"armGroupLabels":34},"PROCEDURE","Massage and educational treatment provided by a licensed massage therapist.",[35],"Group #2",{"type":13,"name":37,"description":38,"armGroupLabels":39},"Provider Directed Care","Provider directed care (i.e. Physical Therapy)",[40,35],"Group #1",[42,46,50,54,57,60,64,67,70],{"measure":43,"description":44,"timeFrame":45},"Modified Oswestry Low Back Pain Disability Index (M-ODI)","The M-ODI is the most commonly used aid for evaluating disability due to LBP This free instrument delivers medical provider information related to functional limitation and pain management.","Baseline Visit, Week 1 Visit, Week 6 Visit, Week 12 Visit, and Final Follow-up Visit (up to 16 weeks after Baseline Visit)",{"measure":47,"description":48,"timeFrame":49},"Satisfaction and Treatment History Self-Reported Data","Participants will self-report differences in healthcare utilization and prescription medication fulfillment, as well as satisfaction with care.","Week 1-12 Visits, and Final Follow-up Visit (up to 16 weeks after Baseline Visit)",{"measure":51,"description":52,"timeFrame":53},"Work Productivity and Activity Impairment Questionnaire (WPAI-LBP)","The Work Productivity and Activity Impairment (WPAI) Low Back Pain (LBP) questionnaire is an instrument used to assess the impact of low back pain on a person's ability to work and perform daily activities. The questionnaire focuses on absenteeism (missing work), presenteeism (reduced productivity at work), and limitations in non-work activities due to low back pain.","Baseline Visit, Week 1-12 Visits, and Final Follow-up Visit (up to 16 weeks after Baseline Visit)",{"measure":55,"description":56,"timeFrame":53},"Defense and Veterans Pain Rating Scale (DVPRS)","The Defense and Veterans Pain Rating Scale (DVPRS 2.0) is a pain assessment tool that utilizes a numerical rating scale enhanced by functional word descriptors, color coding, and pictorial facial expressions matched to pain levels.",{"measure":58,"description":59,"timeFrame":45},"Global Pain Scale (GPS)","The GPS is a comprehensive assessment of pain evaluating pain, emotions, clinical outcomes, and daily activities,. This may be a valuable tool for evaluation and treatment planning for interventional pain management physicians.",{"measure":61,"description":62,"timeFrame":63},"Global Rating of Change Score (GRoC)","The GRoC is a frequently used outcome measure that has ben used to independently score self-perceived improvement in a patient and has been used as an anchor method to determine minimal clinically important change scores. The GRoC is a single-item, recall-based questionnaire of well-being that is based on progress since an initial treatment encounter.","Week 1 Visit, Week 6 Visit, Week 12 Visit, and Final Follow-up Visit (up to 16 weeks after Baseline Visit)",{"measure":65,"description":66,"timeFrame":45},"Patient-Reported Outcomes Measurement Information System (PROMIS-29)","The PROMIS-29 v2.0 profile assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items per domain.",{"measure":68,"description":69,"timeFrame":49},"Physical Therapy Appointment History","How many PT appointments since last study visit, which body part(s) treated, what treatment modalities were performed?",{"measure":71,"timeFrame":53},"Military Specific Duty Status",[],"ALL","18 Years","64 Years",{"inclusion":77,"exclusion":83,"raw_text":106},[78,79,80,81,82],"Active-duty service member","18-64 (inclusive) years of age","Medical evidence of subacute low back pain (as indicated by complications lasting 1-3 months)","Willingness to comply with treatment and follow-up schedule","Ability and willingness to provide written informed consent",[84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105],"Current dx of any of the following:","Presence of significant comorbid pain (e.g., polytrauma)","Cancer - active\u002Fongoing treatment for","Active Infections, including skin lesions and rashes","Flu or other severe cold virus or COVID","Severe depression or anxiety","Symptomatic Inflammatory\u002FAutoimmune diseases such as Rheumatoid","Arthritis and Ankylosing Spondylitis. Acute exacerbation and not in remission","High Grade Spondylolisthesis (Grade III and Grade IV)","Fibromyalgia","Severe Osteoporosis (BMD with T-score of -2.5 or lower, along with the presence of one or more fragility fractures)","Neurogenic conditions","Spinal Stenosis with active neurogenic claudication","Cauda Equina Syndrome - acute","Radiating pain below the knee or in the presence of true Neurological signs (numbness\u002Fweakness)","Historical dx of any of the following:","Spinal Cord injuries with persisting neurogenic sensory or motor loss","Lumbar spine back surgery within the past year","Received spinal interventions (e.g., surgery, nerve ablations, steroid injections, etc.) within the past 6 months","Current use of blood thinners\u002Fanticoagulants","Is enrolled or plans to enroll in another clinical trial during this study that would affect the patient's safety or results of this trial","\\[Females only\\] Currently pregnant (self-reported) or plans to become pregnant during the study intervention period","Inclusion Criteria:\n\n* Active-duty service member\n* 18-64 (inclusive) years of age\n* Medical evidence of subacute low back pain (as indicated by complications lasting 1-3 months)\n* Willingness to comply with treatment and follow-up schedule\n* Ability and willingness to provide written informed consent\n\nExclusion Criteria:\n\n* Current dx of any of the following:\n* Presence of significant comorbid pain (e.g., polytrauma)\n* Cancer - active\u002Fongoing treatment for\n* Active Infections, including skin lesions and rashes\n* Flu or other severe cold virus or COVID\n* Severe depression or anxiety\n* Symptomatic Inflammatory\u002FAutoimmune diseases such as Rheumatoid\n* Arthritis and Ankylosing Spondylitis. Acute exacerbation and not in remission\n* High Grade Spondylolisthesis (Grade III and Grade IV)\n* Fibromyalgia\n* Severe Osteoporosis (BMD with T-score of -2.5 or lower, along with the presence of one or more fragility fractures)\n* Neurogenic conditions\n* Spinal Stenosis with active neurogenic claudication\n* Cauda Equina Syndrome - acute\n* Radiating pain below the knee or in the presence of true Neurological signs (numbness\u002Fweakness)\n* Historical dx of any of the following:\n* Spinal Cord injuries with persisting neurogenic sensory or motor loss\n* Lumbar spine back surgery within the past year\n* Received spinal interventions (e.g., surgery, nerve ablations, steroid injections, etc.) within the past 6 months\n* Current use of blood thinners\u002Fanticoagulants\n* Is enrolled or plans to enroll in another clinical trial during this study that would affect the patient's safety or results of this trial\n* \\[Females only\\] Currently pregnant (self-reported) or plans to become pregnant during the study intervention period",[108],"ADULT",[110],{"facility":111,"status":7,"city":112,"state":113,"zip":114,"country":115,"contacts":116,"geoPoint":125},"Madigan Army Medical Center","Joint Base Lewis McChord","Washington","98431","United States",[117,122],{"name":118,"role":119,"phone":120,"email":121},"Janel Son, MPH","CONTACT","253-968-3288","json@genevausa.org",{"name":123,"role":119,"email":124},"Ghena Grinshpun, DO","german.grinshpun.civ@health.mil",{"lat":126,"lon":127},47.10787,-122.57694,[129,130],{"name":118,"role":119,"phone":120,"email":121},{"name":131,"role":119,"email":132},"Brad M. Isaacson, PhD, MBA, MSF, PMP","brad.isaacson.ctr@usuhs.edu",[134],{"name":135,"affiliation":111,"role":136},"Ghena G. Grinshpun, PhD, MBA, MSF, PMP","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":140,"biomarkers":141},[18],[],{"nct_id":4,"found":143,"summary":144,"prompt_version":154},true,{"design":145,"status":146,"heading":147,"summary":148,"follow_up":149,"word_count":150,"commitments":151,"compensation":152,"drugs_mentioned":153},"This is an interventional study planning to enroll 220 participants. It compares Medical Massage Therapy plus provider-directed care to provider-directed care alone.","completed","Medical Massage Therapy for Sub-Acute Lower Back Pain","This study is looking at whether Medical Massage Therapy (MMT) can help active-duty service members with sub-acute lower back pain (pain lasting 1-3 months). Researchers want to see if MMT, when added to regular care from a healthcare provider, can shorten the time people are on \"Medically Restricted Duty Days\" (MRDD). They also want to see if MMT can reduce pain and how often people need to use healthcare services. You might be able to join if you are an active-duty service member between 18 and 64 years old with sub-acute lower back pain. The study will measure your pain and how well you can do daily activities to see if the treatment is successful. The current status of this study is unclear.","Participants will be followed for up to 16 weeks after their baseline visit.",123,"Participants will have visits at baseline, week 1, week 6, week 12, and a final follow-up visit up to 16 weeks after the start of the study. You will receive either medical massage therapy or provider-directed care.","Not stated in the trial record.",[20],"v2"]